|
Captiva Verde Comprehensive Update
Coquitlam, British Columbia, Nov 02, 2020 - (ACN Newswire) - Captiva Verde Land Corp. (CSE: PWR) (OTC: CPIVF) (the "Company"), is pleased to report an update on all of our major operating business segments plus our recommendation of a financial newsletter written by an award winning portfolio manager.
Financial Newsletter - Grit Capital
Captiva Verde sponsored an investor event in Las Vegas in December 2019 with Grit Capital. Beginning November 1, 2020, Grit Capital has launched a very efficient and easy to read, fun, exceedingly informative, and highly impactful Investment Newsletter that covers emerging trends, themes and investment ideas which is based on where big money and momentum is moving in the market, long before the general investing public studies the available information. The newsletter is written by Genevieve Roch-Decter, CFA, a former $100 Million+ small cap portfolio manager who's fund was ranked #1 for 3 of the 7 years she ran it (as ranked by Globe & Mail - GlobeFunds). We strongly recommend all of our shareholders and all interested friends and family to subscribe to the free newsletter at https://gritcapital.substack.com
Solargram Farms ("SGF")
SGF just completed its 1st year harvest in Renauds Mills NB, growing 13,000 plants over approximately 20 acres within its Health Canada 50 acre licensed outdoor cannabis cultivation footprint (total 130 acres land package for future expansion). SGF averaged 1 person per acre from the grow team to grow the first year harvest and made approximately 95% of the operating costs, variable costs.
SGF obtained its cultivation license on June 26th in the middle of the Covid19 Pandemic and successfully planted, nurtured, and subsequently finished the fall harvest last Sunday. SGF has harvested approximately 16,000kg of cannabis which will yield approximately 3800kg of dried cannabis. SGF has purposely planned produced approximately 500 to 600kg of cured dried flower within the larger harvested product this year, that is destined for bulk sales to customers over the next 4 to 6 weeks that will commence the monetization of sales. This initial planned sales represents less than 15% of the harvest volume that will generate over $1.6 million in sales that is expected to cover all of the 2021 forecasted operating expenses before commencing producing the much higher valued, oil extracted based cannabis products that have been requested by our customers.
The balance of the harvested product has now been milled and will be sent to the extraction partner for oil processing as soon as SGF's obtains the Health Canada sales and processing license which is expected within six weeks. This processed oil extract will allow SGF to produce planned scheduled products that will satisfy the customer's request for product. The first year estimated sales will be in excess of $15,000,000 starting early 2021 at a forecast 60-70% gross margin. The two main harvested genetics which comprises 85% of the crop has initially tested 19%-22% THC which is a major win for such a large outdoor grown crop. Further broader representative sample testing will be done once the harvest is completely dried within another week which we expect will be within the same relevant range previously obtained.
SGF's has commenced growing the 2021 season mothers and clones and expects to produce 20,000 plants with very low additional capital costs, expecting that will in fact more than double the 2021 production yield and sales on the same 2020 production footprint.
We remain a debt free company and, as a result, will be able to provide shareholders with a significant return on investment once sales and profitability materializes in 2021.
Sage Ranch
The final Planning Commission approval looks like it will be on December 9. After that date we wait 45 days and we can begin construction. We have over 200 families on the waiting list to purchase homes and we have engaged Keller Williams - Paul Morris Forward Living to sell our remaining units to the 1 million people who live within a 40 minute drive and a further 25 million people who live within a 2 hour drive of the subdivision.
We expect the entire 1,000 units ($400 Million) to sell out and this upcoming Planning Commission approval is a game changing event. Entry Level Real Estate prices have soared and demand is very high as California is short 2.4 million entry level homes.
Esmeralda
Our new pharmaceutical manufacturing plant structure is completed. We have 3 more weeks of electrical, plumbing and finishing touches. We have generated an equipment list and the final step is purchasing and installing the manufacturing equipment. We expect this completed by year end which is to fulfil our USD $142 Million yearly sales contract with the Health Care Workers Union.
Miss Envy
We have designed some product for Asia and getting very positive feedback on the product quality. Working towards the next steps of larger acceptance by various groups in Asia. Miss Envy is providing both Mexico (Esmeralda) and Solargram with product strategies and assistance in preparing for revenue sales in both Canada and Mexico.
On Behalf of the Board of Directors "Jeffrey Ciachurski" Jeffrey Ciachurski Chief Executive Officer and Director Cell: (949) 903-5906 E-mail: westernwind@shaw.ca
Cautionary Note Regarding Forward-Looking Information
This release includes certain statements that may be deemed "forward-looking statements". All statements in this release, other than statements of historical facts, that address events or developments that the Company expects to occur, are forward-looking statements. Forward-looking statements are statements that are not historical facts and are generally, but not always, identified by the words "expects", "plans", "anticipates", "believes", "intends", "estimates", "projects", "potential" and similar expressions, or that events or conditions "will", "would", "may", "could" or "should" occur. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results may differ materially from those in the forward-looking statements. Factors that could cause the actual results to differ materially from those in forward-looking statements include regulatory actions, market prices, and continued availability of capital and financing, and general economic, market or business conditions.
Investors are cautioned that any such statements are not guarantees of future performance and actual results or developments may differ materially from those projected in the forward-looking statements. Forward-looking statements are based on the beliefs, estimates and opinions of the Company's management on the date the statements are made. Except as required by applicable securities laws, the Company undertakes no obligation to update these forward-looking statements in the event that management's beliefs, estimates or opinions, or other factors, should change.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/67309
Source: Captiva Verde Land Corp. Sectors: Agritech, Food & Beverage, BioTech, Healthcare & Pharm
Copyright ©2026 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
|
Latest Release
 MHI Commends Outstanding Examples of Implementing its New Management Policy "ITO" Mar 18, 2026 13:09 JST
|  FILMART and EntertainmentPulse open today Mar 17, 2026 21:41 JST
|  TANAKA PRECIOUS METAL GROUP Provides Medals, Commemorative Items, and Trophies as Category Sponsor (Awards Ceremonies) for the LIGA.i Blind Soccer Top League 2025 Mar 17, 2026 21:00 JST
|  Eisai Established the Global Capability Centre in Visakhapatnam, India, to Standardize Global IT Infrastructure Operations and Digital Transformation Mar 17, 2026 19:49 JST
|  Successful Flight Demonstration of Mission Autonomy Developed for Use in Unmanned Aerial Vehicles Mar 17, 2026 14:11 JST
|  The University of Tokyo and NEC conclude a Strategic Collaboration Agreement to promote a prosperous society where people and AI succeed together Mar 17, 2026 12:34 JST
|  Hitachi Energy Japan Recognized as a 2026 Health & Productivity Management Outstanding Organization (Large Enterprise Category) Mar 16, 2026 16:20 JST
|  Fujitsu Japan and Teikyo University Hospital launch joint proof of concept to build mechanism for data analysis and referred-patient management Mar 16, 2026 12:55 JST
|  FWD Group delivers record full year 2025 results with profitable growth, improved capital and cash flow generation Mar 16, 2026 10:25 JST
|  Mitsubishi Shipbuilding Completes Handover of WAKASHIO MARU Training Ship for National Institute of Technology, Toyama College Mar 13, 2026 16:01 JST
|  Mitsubishi Heavy Industries to Introduce 10MW-Class Centrifugal Chiller for Next-Generation AI Data Centers in North America Mar 13, 2026 14:10 JST
|  Spritzer Sparkling's 'Serikan Raya, Sparkling-kan Suasana' Festive Fusion Message Promotes Togetherness and Tradition with a Light, Modern Twist Mar 13, 2026 12:45 JST
|  Hitachi to deliver the world's first 550 kV gas-insulated switchgear in which the entire equipment is SF(6)-free to Chubu Electric Power Grid Mar 12, 2026 19:40 JST
|  Honda Announces Losses Associated with Reassessment of Automobile Electrification Strategy; Revision to Forecast for Consolidated Financial Results; and Future Direction
Mar 12, 2026 19:02 JST
|  Japantastics Introduces the World of Kodaimoji, Bringing Ancient Characters into Modern Spaces Mar 12, 2026 19:00 JST
|  Eisai Launches Awareness Campaign on Importance of Sleep Through "Pokemon Sleep" Collaboration Mar 12, 2026 17:21 JST
|  NEC Develops Physical AI That Anticipates Human Movement and Psychological States Mar 12, 2026 16:41 JST
|  NEC and The University of Tokyo calculate carbon accumulation rates in Malaysian national park with a 9.4% margin of error Mar 12, 2026 12:02 JST
|  Everest Medicines Announces Commercial Launch and First Prescription for VELSIPITY(R) in Mainland China, Addressing Unmet Need in Moderately to Severely Active Ulcerative Colitis Mar 11, 2026 20:15 JST
|  Eisai to Present the Latest Data on Long-Term, Real-World Treatment with Lecanemab at the AD/PD(TM) 2026 Annual Meeting Mar 11, 2026 12:07 JST
|
More Latest Release >>
|